510(k) K222559
K222559 is an FDA 510(k) premarket notification submitted by Becton, Dickinson and Company for the device "BD BACTEC Myco/F Lytic Culture Vials". The FDA issued a decision of Substantially Equivalent on March 24, 2023. The device falls under product code MDB (System, Blood Culturing), a Class I device regulated under 21 CFR 866.2560. Becton, Dickinson and Company has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 24, 2023
- Date Received
- August 24, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Blood Culturing
- Device Class
- Class I
- Regulation Number
- 866.2560
- Review Panel
- MI
- Submission Type